KDM5 family members (A, B, C and D) that demethylate H3K4me3 have been shown to be involved in human cancers. Here we performed screening for KDM5A inhibitors from chemical libraries using the AlphaScreen method and identified a battery of screening hits that inhibited recombinant KDM5A. These compounds were further subjected to cell-based screening using a reporter gene that responded to KDM5A inhibition and 6 compounds were obtained as candidate inhibitors. When further confirmation of their inhibition activity on cellular KDM5A was made by immunostaining H3K4me3 in KDM5A-overexpressing cells, ryuvidine clearly repressed H3K4me3 demethylation. Ryuvidine prevented generation of gefitinib-tolerant human small-cell lung cancer PC9 cells and also inhibited the growth of the drug-tolerant cells at concentrations that did not affect the growth of parental PC9 cells. Ryuvidine inhibited not only KDM5A but also recombinant KDM5B and C; KDM5B was the most sensitive to the inhibitor. These results warrant that ryuvidine may serve as a lead compound for KDM5 targeted therapeutics.
Conflict of interest statement
TM is a board member of Frontier Pharma, Inc. RS is employed as a Research Fellow by Frontier Pharma, Inc. The other authors have declared that no competing interests exist.
Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines.Cancers (Basel). 2019 Jan 15;11(1):92. doi: 10.3390/cancers11010092. Cancers (Basel). 2019. PMID: 30650517 Free PMC article.
Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.Oncotarget. 2016 Jun 28;7(26):39931-39944. doi: 10.18632/oncotarget.9539. Oncotarget. 2016. PMID: 27224921 Free PMC article.
Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs.iScience. 2019 Feb 22;12:168-181. doi: 10.1016/j.isci.2019.01.012. Epub 2019 Jan 11. iScience. 2019. PMID: 30685712 Free PMC article.
Investigations on small molecule inhibitors targeting the histone H3K4 tri-methyllysine binding PHD-finger of JmjC histone demethylases.Version 2. Bioorg Med Chem. 2018 Jul 15;26(11):2984-2991. doi: 10.1016/j.bmc.2018.03.030. Epub 2018 Mar 19. Bioorg Med Chem. 2018. PMID: 29764755 Free PMC article. Review.
KDM5 demethylases and their role in cancer cell chemoresistance.Int J Cancer. 2019 Jan 15;144(2):221-231. doi: 10.1002/ijc.31881. Epub 2018 Nov 26. Int J Cancer. 2019. PMID: 30246379 Review.